Tagged Articles

stomach cancer 5 articles

New study may link popular acid-reducing drugs to stomach cancer

Published this month in PLOS Pathogens, microbiologists at Stanford and the University of Oregon found that acid-reducing proton pump inhibitors, or PPIs, such as omeprazole, commonly sold under the brand name Prilosec, may encourage the spreading of a bacterium that is linked to stomach cancer. “Helicobacter pylori is a bacterium that chronically infects the stomachs of 50 percent of humans, and infection can lead to serious diseases like peptic ulcers and stomach cancer,” say the study authors. “Stanford microbiologist Manuel Amieva, MD and his colleagues identified receptors H. pylori uses to detect and flee the detested acidity of its chosen ... Read More

Low dose aspirin therapy may help prevent pancreatic cancer

A low, daily dose of aspirin has been praised for its cardiovascular benefits, but new research shows that the therapy may also ward off pancreatic cancer, one of the deadliest forms of the disease. The study, conducted by researchers at the Yale School of Public Health, claims daily low-dose aspirin therapy can lower pancreatic cancer risk by up to 48 percent. Low-dose aspirn therapy has already been credited for reducing risk of ovarian, colorectal, stomach, esophageal, prostate, breast, lung, and skin cancers. Researchers studied information on aspirin use and medical histories for 362 people with pancreatic cancer and 690 people ... Read More

FDA warns that chemotherapy drug may cause patients to feel drunk

The intravenous chemotherapy drug docetaxel contains ethanol, also known as alcohol, which can cause patients to feel intoxicated, or drunk, during and after treatment, the Food and Drug Administration (FDA) warned in a safety communication. The agency is ordering all docetaxel drug products to add a warning to their safety labels regarding this possible side effect. Docetaxel is a prescription chemotherapy drug used to treat various types of cancer including breast, prostate, stomach, head and neck, and non-small-cell lung cancers. It is known by the brand names Taxotere and Docefrez. Known as a taxane, the drug works by interfering with microtubules, ... Read More

Many breast cancer patients don’t seek prompt treatment for drug-related heart failure

About 12 percent of breast cancer patients treated with chemotherapy drugs develop heart failure within three years after cancer treatment, but only a third saw a cardiologist within 90 days of the onset of symptoms, according to a new study. The research was presented at the American Cancer Society meeting in Baltimore. The study involved data from about 8,400 breast cancer patients age 65 and older who were treated either with chemotherapy drugs called anthracyclines, or a targeted therapy trastuzumab. Both drugs have been previously linked to heart problems. Researchers said that patients who saw a cardiologist were more likely ... Read More

Bacterium may increase risk for type 2 diabetes

A type of ulcer-causing bacterium may be linked to the development of type 2 diabetes in overweight and obese adults, and may offer clues on how to prevent the development of diabetes in these individuals in the future, according to a NYU Langone Medical Center study. The bacterium, known as Helicobacter pylori, is an organism that can affect both children and adults, yet in entirely different ways. In children, it has been found to protect against asthma and allergy. Infections beginning in childhood have also been linked decades later to stomach and small intestine ulcers, as well as an increased ... Read More